Loss of transactivation and transrepression function, and not RPA binding, alters growth suppression by p53.
Lorene M. Leiter(Brigham and Women's Hospital), Anindya Dutta(Indian Institute of Technology Bombay), Masafumi Tanaka(Cold Spring Harbor Laboratory), Tara Marathe(Harvard University Press), Junjie Chen(The University of Texas MD Anderson Cancer Center)
PubMed
June 20, 1996
Cited by 20
Related Papers
Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project
|Nature|2007|5.3k
p21 in cancer: intricate networks and multiple activities
|Nature reviews. Cancer|2009|2.8k
DNA Replication in Eukaryotic Cells
|Annual Review of Biochemistry|2002|2k
MicroRNAs in Cancer
|Annual Review of Pathology Mechanisms of Disease|2008|1.6k
A novel class of small RNAs: tRNA-derived RNA fragments (tRFs)
|Genes & Development|2009|1.2k